BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci 2018;19:E2413. [PMID: 30115834 DOI: 10.3390/ijms19082413] [Cited by in Crossref: 59] [Cited by in F6Publishing: 85] [Article Influence: 14.8] [Reference Citation Analysis]
Number Citing Articles
1 Gao X, Gao B, Li S. Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma. Front Immunol 2022;13:1002742. [DOI: 10.3389/fimmu.2022.1002742] [Reference Citation Analysis]
2 Li Q, Mao J, Meng X. Comprehensive Characterization of Immune Landscape Based on Tumor Microenvironment for Oral Squamous Cell Carcinoma Prognosis. Vaccines 2022;10:1521. [DOI: 10.3390/vaccines10091521] [Reference Citation Analysis]
3 Hu Z, Zhou J, Li Y, Luan Y, Li H, Jia B, Xie Z, Cheng B, Wu T. Peripheral immune signature resembles tumor microenvironment and predicts clinical outcomes in head and neck squamous cell carcinoma. Front Immunol 2022;13:915207. [DOI: 10.3389/fimmu.2022.915207] [Reference Citation Analysis]
4 Banakar M, Ardekani ST, Zare R, Malekzadeh M, Mirhadi H, Khademi B, Rokaya D, Eswaramoorthy R. Oral Squamous Cell Carcinoma: The Role of BIRC6 Serum Level. BioMed Research International 2022;2022:1-4. [DOI: 10.1155/2022/5425478] [Reference Citation Analysis]
5 Ryan NM, Lamenza FF, Upadhaya P, Pracha H, Springer A, Swingler M, Siddiqui A, Oghumu S. Black raspberry extract inhibits regulatory T-cell activity in a murine model of head and neck squamous cell carcinoma chemoprevention. Front Immunol 2022;13:932742. [DOI: 10.3389/fimmu.2022.932742] [Reference Citation Analysis]
6 Shen T, Zhang J, Wang Y, Liu B. FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma. J Immunol Res 2022;2022:8443392. [PMID: 35733916 DOI: 10.1155/2022/8443392] [Reference Citation Analysis]
7 Leuci S, Coppola N, Viglione AP, Blasi A, Ramaglia L, Cantile T, Mignogna MD. Knowledge, attitude, and practice in oral cancer: A national survey on 150 dental hygienists. Oral Dis 2022. [PMID: 35708544 DOI: 10.1111/odi.14281] [Reference Citation Analysis]
8 Wang S, Zhang S, Lin Z, Ma J, Zhu L, Liao G. Identification and Validation of an Apoptosis-Related Gene Prognostic Signature for Oral Squamous Cell Carcinoma. Front Oncol 2022;12:889049. [DOI: 10.3389/fonc.2022.889049] [Reference Citation Analysis]
9 Zhang Q, Wang F, Liang J, Kuang W, Zeng X, Zhang X. Photodynamic therapy for extensive oral verrucous/granular leukoplakia with moderate-to-severe dysplasia: A case study. Photodiagnosis and Photodynamic Therapy 2022. [DOI: 10.1016/j.pdpdt.2022.102910] [Reference Citation Analysis]
10 Fan T, Wang X, Zhang S, Deng P, Jiang Y, Liang Y, Jie S, Wang Q, Li C, Tian G, Zhang Z, Ren Z, Li B, Chen Y, He Z, Luo Y, Chen M, Wu H, Yu Z, Pi H, Zhou Z, Zhang Z. NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy. Sig Transduct Target Ther 2022;7. [DOI: 10.1038/s41392-022-00939-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Jiang D, Xiao F, Liu L, Meng Z, Zhang C. Effects of Traditional Chinese Medicine Anticancer Decoction Combined with Basic Chemotherapy and Nursing Intervention on Oral Cancer Patients after Surgery and Its Effect on Tumor Markers and Immune Function. Biomed Res Int 2022;2022:6341381. [PMID: 35402612 DOI: 10.1155/2022/6341381] [Reference Citation Analysis]
12 He Y, Dong Y, Zhang X, Ding Z, Song Y, Huang X, Chen S, Wang Z, Ni Y, Ding L. Lipid Droplet-Related PLIN2 in CD68+ Tumor-Associated Macrophage of Oral Squamous Cell Carcinoma: Implications for Cancer Prognosis and Immunotherapy. Front Oncol 2022;12:824235. [PMID: 35372038 DOI: 10.3389/fonc.2022.824235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang H, Che Y, Xuan B, Wu X, Li H. Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2). Bioengineered 2022;13:8785-97. [PMID: 35333683 DOI: 10.1080/21655979.2022.2051886] [Reference Citation Analysis]
14 Schere-Levy C, Suberbordes M, Ferri DM, Ayre M, Gattelli A, Kordon EC, Raimondi AR, Walther T. Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice. Int J Mol Sci 2022;23:3642. [PMID: 35409002 DOI: 10.3390/ijms23073642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Tkacz M, Tarnowski M, Poniewierska-baran A, Serwin K, Madej-michniewicz A, Deskur A, Czerny B, Starzyńska T. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022;12:700. [DOI: 10.3390/diagnostics12030700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Sasahira T, Kurihara-shimomura M, Shimojjukoku Y, Shima K, Kirita T. Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine. JPM 2022;12:413. [DOI: 10.3390/jpm12030413] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang XY, Tang H, Liu Y, Du N, Tian S, Dou YQ. circYap inhibits oral squamous cell carcinoma by arresting cell cycle. Acta Odontol Scand 2022;80:117-24. [PMID: 34280323 DOI: 10.1080/00016357.2021.1946136] [Reference Citation Analysis]
18 Xie P, Wu S, Guo L, Ren J, Cai K, Zhou M, Liu W, Yang S. Identification of Candidate Target Genes and Immune Cells in Oral Squamous Cell Carcinoma. Comput Math Methods Med 2021;2021:5802110. [PMID: 35003322 DOI: 10.1155/2021/5802110] [Reference Citation Analysis]
19 Liu X, Ma X, Li H, Wang Y, Mao M, Liang C, Hu Y. LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis. Bioengineered 2022;13:1162-73. [DOI: 10.1080/21655979.2021.2018092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zheng X, Du F, Gong X, Xu P. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637. Bioengineered 2022;13:440-54. [PMID: 34967281 DOI: 10.1080/21655979.2021.2009317] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Jin Y, Zuo HX, Li MY, Zhang ZH, Xing Y, Wang JY, Ma J, Li G, Piao H, Gu P, Jin X. Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo. Front Pharmacol 2021;12:774231. [PMID: 34899336 DOI: 10.3389/fphar.2021.774231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ou D, Wu Y. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma. BMC Cancer 2021;21:1327. [PMID: 34903206 DOI: 10.1186/s12885-021-09058-y] [Reference Citation Analysis]
23 Markowicz J, Uram Ł, Wołowiec S, Rode W. Biotin Transport-Targeting Polysaccharide-Modified PAMAM G3 Dendrimer as System Delivering α-Mangostin into Cancer Cells and C. elegans Worms. Int J Mol Sci 2021;22:12925. [PMID: 34884739 DOI: 10.3390/ijms222312925] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Li X, Yang W. IRF2-induced Claudin-7 suppresses cell proliferation, invasion and migration of oral squamous cell carcinoma. Exp Ther Med 2022;23:7. [PMID: 34815759 DOI: 10.3892/etm.2021.10929] [Reference Citation Analysis]
25 Liu X, He Z, Qu Y, Meng Q, Qin L, Hu Y. Circulating Natural Autoantibodies to HER2-Derived Peptides Performed Antitumor Effects on Oral Squamous Cell Carcinoma. Front Pharmacol 2021;12:693989. [PMID: 34803666 DOI: 10.3389/fphar.2021.693989] [Reference Citation Analysis]
26 Jin X, Huang T, Ma C, Duan J, Li R, Zhang W, Tian W. Protein tyrosine kinase 7-knockdown inhibits oral squamous cell carcinoma cell viability, proliferation, migration and invasion via downregulating dishevelled segment polarity protein 3 expression. Exp Ther Med 2021;22:1372. [PMID: 34659518 DOI: 10.3892/etm.2021.10806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Goldoni R, Scolaro A, Boccalari E, Dolci C, Scarano A, Inchingolo F, Ravazzani P, Muti P, Tartaglia G. Malignancies and Biosensors: A Focus on Oral Cancer Detection through Salivary Biomarkers. Biosensors (Basel) 2021;11:396. [PMID: 34677352 DOI: 10.3390/bios11100396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Zhang SQ, Chen HB, Liu J, Dai WJ, Lu QQ, Li JC. Research status and prospects of acupuncture for prevention and treatment of chemo- and radiotherapy-induced salivary gland dysfunction in head and neck cancer. Anat Rec (Hoboken) 2021;304:2381-96. [PMID: 34626452 DOI: 10.1002/ar.24784] [Reference Citation Analysis]
29 Jin Z, Jiang S. Long non-coding RNA TTN-AS1/microRNA-199a-3p/runt-related transcription factor 1 gene axis regulates the progression of oral squamous cell carcinoma. Bioengineered 2021;12:7724-36. [PMID: 34606420 DOI: 10.1080/21655979.2021.1982324] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Ghantous Y, Omar M, Broner EC, Agrawal N, Pearson AT, Rosenberg AJ, Mishra V, Singh A, El-Naaj IA, Savage PA, Sidransky D, Marchionni L, Izumchenko E. A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma. Int J Cancer 2021. [PMID: 34569064 DOI: 10.1002/ijc.33828] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Yi C, Zhang X, Li H, Chen G, Zeng B, Li Y, Wang C, He Y, Chen X, Huang Z, Yu D. EPHB4 Regulates the Proliferation and Metastasis of Oral Squamous Cell Carcinoma through the HMGB1/NF-κB Signalling Pathway. J Cancer 2021;12:5999-6011. [PMID: 34539874 DOI: 10.7150/jca.59331] [Reference Citation Analysis]
32 Georgaki M, Theofilou VI, Pettas E, Stoufi E, Younis RH, Kolokotronis A, Sauk JJ, Nikitakis NG. Understanding the complex pathogenesis of oral cancer: A comprehensive review. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:566-79. [PMID: 34518141 DOI: 10.1016/j.oooo.2021.04.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Lu X, Chen L, Li Y, Huang R, Meng X, Sun F. Long non-coding RNA LINC01207 promotes cell proliferation and migration but suppresses apoptosis and autophagy in oral squamous cell carcinoma by the microRNA-1301-3p/lactate dehydrogenase isoform A axis. Bioengineered 2021;12:7780-93. [PMID: 34463208 DOI: 10.1080/21655979.2021.1972784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
34 Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Zou C. lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-κB Signaling. J Immunol Res 2021;2021:5524231. [PMID: 34414241 DOI: 10.1155/2021/5524231] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
35 Chang KW, Hung WW, Chou CH, Tu HF, Chang SR, Liu YC, Liu CJ, Lin SC. LncRNA MIR31HG Drives Oncogenicity by Inhibiting the Limb-Bud and Heart Development Gene (LBH) during Oral Carcinoma. Int J Mol Sci 2021;22:8383. [PMID: 34445087 DOI: 10.3390/ijms22168383] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
36 Xia YC, Cao J, Yang J, Zhang Y, Li YS. lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p. Dis Markers 2021;2021:2217663. [PMID: 34336002 DOI: 10.1155/2021/2217663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhao Y, Huang J, Chen J. The integration of differentially expressed genes based on multiple microarray datasets for prediction of the prognosis in oral squamous cell carcinoma. Bioengineered 2021;12:3309-21. [PMID: 34224327 DOI: 10.1080/21655979.2021.1947076] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
38 Watanabe K, Matsumoto A, Tsuda H, Iwamoto S. N4BP2L1 interacts with dynactin and contributes to GLUT4 trafficking and glucose uptake in adipocytes. J Diabetes Investig 2021. [PMID: 34197691 DOI: 10.1111/jdi.13623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Sun X, Yan H. MicroRNA-99a-5p suppresses cell proliferation, migration, and invasion by targeting isoprenylcysteine carboxylmethyltransferase in oral squamous cell carcinoma. J Int Med Res 2021;49:300060520939031. [PMID: 34038200 DOI: 10.1177/0300060520939031] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Zhou J, Li H, Cheng B, Cao R, Zou F, Yang D, Liu X, Song M, Wu T. Derivation and Validation of a Prognostic Scoring Model Based on Clinical and Pathological Features for Risk Stratification in Oral Squamous Cell Carcinoma Patients: A Retrospective Multicenter Study. Front Oncol 2021;11:652553. [PMID: 34123806 DOI: 10.3389/fonc.2021.652553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Li K, Fan X, Yan Z, Zhan J, Cao F, Jiang Y. Circ_0000745 strengthens the expression of CCND1 by functioning as miR-488 sponge and interacting with HuR binding protein to facilitate the development of oral squamous cell carcinoma. Cancer Cell Int 2021;21:271. [PMID: 34020639 DOI: 10.1186/s12935-021-01884-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Mello FW, Melo G, Guerra ENDS, Warnakulasuriya S, Garnis C, Rivero ERC. Prognostic biomarkers for malignant transformation of oral potentially malignant disorders: a scoping review protocol. JBI Evid Synth 2020;18:1349-57. [PMID: 32813385 DOI: 10.11124/JBISRIR-D-19-00259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Ferreira AK, Carvalho SH, Granville-Garcia AF, Sarmento DJ, Agripino GG, Abreu MH, Melo MC, Caldas AD Jr, Godoy GP. Survival and prognostic factors in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2021;26:e387-92. [PMID: 33037796 DOI: 10.4317/medoral.24242] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
44 Hsieh MH, Lu HJ, Lin CW, Lee CY, Yang SJ, Wu PH, Chen MK, Yang SF. Genetic Variants of lncRNA GAS5 Are Associated with the Clinicopathologic Development of Oral Cancer. J Pers Med 2021;11:348. [PMID: 33925911 DOI: 10.3390/jpm11050348] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
45 Pennacchiotti G, Valdés-Gutiérrez F, González-Arriagada WA, Montes HF, Parra JMR, Guida VA, Gómez SE, Guerrero-Gimenez ME, Fernandez-Muñoz JM, Zoppino FCM, Carón RW, Ezquer ME, Fernández-Ramires R, Bruna FA. SPINK7 expression changes accompanied by HER2, P53 and RB1 can be relevant in predicting oral squamous cell carcinoma at a molecular level. Sci Rep 2021;11:6939. [PMID: 33767253 DOI: 10.1038/s41598-021-86208-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Čelešnik H, Büdefeld T, Čizmarević B, Švagan M, Potočnik U. MIR137/MIR2682 locus is associated with perineural invasiveness in head and neck cancer. J Oral Pathol Med 2021. [PMID: 33740841 DOI: 10.1111/jop.13174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Liu B, Zhao N, Zhou Y, Lu Y, Chen W, Huang Z, Wang D, Xu Y, Wai Ping Yam J, Cui Y. Circular RNA circ_ABCB10 in cancer. Clin Chim Acta 2021;518:93-100. [PMID: 33746018 DOI: 10.1016/j.cca.2021.03.010] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
48 Yu Q, Du Y, Wang S, Zheng X. LncRNA PART1 promotes cell proliferation and inhibits apoptosis of oral squamous cell carcinoma by blocking EZH2 degradation. J Biochem 2021:mvab026. [PMID: 33725092 DOI: 10.1093/jb/mvab026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Wang HC, Chan LP, Wu CC, Chang SJ, Moi SH, Luo CW, Pan MR. Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer. Int J Mol Sci 2021;22:2402. [PMID: 33673690 DOI: 10.3390/ijms22052402] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Yoon AJ, Santella RM, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, Peters SM, Stewart CR, Momen-Heravi F, Troob S, Levin M, AkhavanAghdam Z, Shackelford AJ, Canterbury CR, Shimonosono M, Hernandez BY, McDowell BD, Nakagawa H. MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell Carcinoma. J Oncol 2021;2021:8292453. [PMID: 33510789 DOI: 10.1155/2021/8292453] [Reference Citation Analysis]
51 Hu S, Huang B, Pu Y, Xia C, Zhang Q, Guo S, Wang Y, Huang X. A thermally activated delayed fluorescence photosensitizer for photodynamic therapy of oral squamous cell carcinoma under low laser intensity. J Mater Chem B 2021;9:5645-55. [PMID: 34190310 DOI: 10.1039/d1tb00719j] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
52 Bhattacharyya S, Ray S, Saha D, Mustafi SM, Alam N, Sarkar A, Murmu N. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach. Pathol Res Pract 2021;218:153287. [PMID: 33454586 DOI: 10.1016/j.prp.2020.153287] [Reference Citation Analysis]
53 Alexandra T, Marina IM, Daniela M, Ioana SI, Maria B, Radu R, Maria TA, Tudor S, Maria G. Autophagy-A Hidden but Important Actor on Oral Cancer Scene. Int J Mol Sci 2020;21:E9325. [PMID: 33297472 DOI: 10.3390/ijms21239325] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
54 Wang D, Gao J, Zhao C, Li S, Zhang D, Hou X, Zhuang X, Liu Q, Luo Y. Cyclin G2 Inhibits Oral Squamous Cell Carcinoma Growth and Metastasis by Binding to IGFBP3 and Regulating the FAK-SRC-STAT Signaling Pathway. Front Oncol 2020;10:560572. [PMID: 33240810 DOI: 10.3389/fonc.2020.560572] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Kulkarni S, Solomon M, Chandrashekar C, Shetty N, Carnelio S. Spalt-like transcription factor 4 expression in oral epithelial dysplasia and oral squamous cell carcinoma: An immunohistochemical appraisal. J Carcinog 2020;19:12. [PMID: 33679242 DOI: 10.4103/jcar.JCar_13_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Bastos P, Carpentier G, Patel V, Papy-Garcia D, Watson T, Cook R. Real-Time Optical Vascular Imaging, a new method for the diagnosis and monitoring of oral diseases. J Microsc 2020. [PMID: 33119132 DOI: 10.1111/jmi.12975] [Reference Citation Analysis]
57 Lu N, Yin Y, Yao Y, Zhang P. SNHG3/miR-2682-5p/HOXB8 promotes cell proliferation and migration in oral squamous cell carcinoma. Oral Dis 2021;27:1161-70. [PMID: 32989886 DOI: 10.1111/odi.13656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
58 Zhang Y, Lin C, Wang X, Ji T. Calcitonin gene-related peptide: A promising bridge between cancer development and cancer-associated pain in oral squamous cell carcinoma. Oncol Lett 2020;20:253. [PMID: 32994816 DOI: 10.3892/ol.2020.12116] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Yu L, Huo L, Shao X, Zhao J. lncRNA SNHG5 promotes cell proliferation, migration and invasion in oral squamous cell carcinoma by sponging miR-655-3p/FZD4 axis. Oncol Lett 2020;20:310. [PMID: 33093919 DOI: 10.3892/ol.2020.12173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zhu X, Qin X, Wang X, Wang Y, Cao W, Zhang J, Chen W. Oral cancer cell‑derived exosomes modulate natural killer cell activity by regulating the receptors on these cells. Int J Mol Med 2020;46:2115-25. [PMID: 33125101 DOI: 10.3892/ijmm.2020.4736] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
61 Shoucair I, Weber Mello F, Jabalee J, Maleki S, Garnis C. The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis. Int J Mol Sci 2020;21:E6837. [PMID: 32957712 DOI: 10.3390/ijms21186837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
62 Amôr NG, Buzo RF, Ortiz RC, Lopes NM, Saito LM, Mackenzie IC, Rodini CO. In vitro and in vivo characterization of cancer stem cell subpopulations in oral squamous cell carcinoma. J Oral Pathol Med 2021;50:52-9. [PMID: 32816395 DOI: 10.1111/jop.13101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
63 Eckert AW, Kappler M, Große I, Wickenhauser C, Seliger B. Current Understanding of the HIF-1-Dependent Metabolism in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E6083. [PMID: 32846951 DOI: 10.3390/ijms21176083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
64 Lee TY, Tseng YH. The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence. Biomolecules 2020;10:E1150. [PMID: 32781654 DOI: 10.3390/biom10081150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
65 Li W, Zhu Q, Zhang S, Liu L, Zhang H, Zhu D. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis. Oral Oncol 2020;111:104946. [PMID: 32763778 DOI: 10.1016/j.oraloncology.2020.104946] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
66 Kurihara-Shimomura M, Sasahira T, Shimomura H, Kirita T. Peroxidan Plays a Tumor-Promoting Role in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E5416. [PMID: 32751434 DOI: 10.3390/ijms21155416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
67 Yin Y, Tan Y, Yao Y, Lu N, Zhang F. SNHG12/miR-326/E2F1 feedback loop facilitates the progression of oral squamous cell carcinoma. Oral Dis 2020;26:1631-9. [PMID: 32506729 DOI: 10.1111/odi.13458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
68 Peng Q, Yang JY, Zhou G. Emerging functions and clinical applications of exosomes in human oral diseases. Cell Biosci 2020;10:68. [PMID: 32489584 DOI: 10.1186/s13578-020-00424-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
69 Sasahira T, Kurihara-Shimomura M, Nishiguchi Y, Shimomura H, Kirita T. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma. Int J Mol Sci 2020;21:E3655. [PMID: 32455867 DOI: 10.3390/ijms21103655] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
70 Irani S, Barati I, Badiei M. Periodontitis and oral cancer - current concepts of the etiopathogenesis. Oncol Rev 2020;14:465. [PMID: 32231765 DOI: 10.4081/oncol.2020.465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
71 Chien MH, Yang WE, Yang YC, Ku CC, Lee WJ, Tsai MY, Lin CW, Yang SF. Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells. Cancers (Basel) 2020;12:E703. [PMID: 32188144 DOI: 10.3390/cancers12030703] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
72 Yoon AJ, Wang S, Kutler DI, Carvajal RD, Philipone E, Wang T, Peters SM, LaRoche D, Hernandez BY, McDowell BD, Stewart CR, Momen-Heravi F, Santella RM. MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. Head Neck 2020;42:1699-712. [PMID: 31981257 DOI: 10.1002/hed.26089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
73 Shimomura H, Sasahira T, Nakashima C, Kurihara-Shimomura M, Kirita T. Non-SMC Condensin I Complex Subunit H (NCAPH) Is Associated with Lymphangiogenesis and Drug Resistance in Oral Squamous Cell Carcinoma. J Clin Med 2019;9:E72. [PMID: 31892156 DOI: 10.3390/jcm9010072] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
74 Chen YL, Liu KJ, Jang CW, Hsu CC, Yen YC, Liu YL, Chuang TH, Wang SH, Fu YK, Kuo CC, Chen YW. ERK Activation Modulates Cancer Stemness and Motility of a Novel Mouse Oral Squamous Cell Carcinoma Cell Line. Cancers (Basel) 2019;12:E61. [PMID: 31878324 DOI: 10.3390/cancers12010061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
75 Li K, Guo Q, Zhang X, Dong X, Liu W, Zhang A, Li Y, Yan J, Jia G, Zheng Z, Tang W, Pan L, An M, Zhang B, Liu S, Fu B. Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value. Clin Exp Immunol 2020;199:172-81. [PMID: 31652350 DOI: 10.1111/cei.13389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
76 Sadighbayan D, Sadighbayan K, Khosroushahi AY, Hasanzadeh M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends in Analytical Chemistry 2019;119:115609. [DOI: 10.1016/j.trac.2019.07.020] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
77 Watanabe K, Yokota K, Yoshida K, Matsumoto A, Iwamoto S. A novel upstream transcription factor 1 target gene N4bp2l1 that regulates adipogenesis. Biochem Biophys Rep 2019;20:100676. [PMID: 31440585 DOI: 10.1016/j.bbrep.2019.100676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
78 Singh P, Augustine D, Rao RS, Patil S, Sowmya SV, Haragannavar VC, Nambiar S. Interleukin-1beta and Caspase-3 expression serve as independent prognostic markers for metastasis and survival in oral squamous cell carcinoma. Cancer Biomark 2019;26:109-22. [PMID: 31356195 DOI: 10.3233/CBM-190149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Garau LM, Muccioli S, Caponi L, Maccauro M, Manca G. Sentinel lymph node biopsy in oral–oropharyngeal squamous cell carcinoma: standards, new technical procedures, and clinical advances. Clin Transl Imaging 2019;7:337-56. [DOI: 10.1007/s40336-019-00338-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
80 Hao Y, Zhang C, Sun Y, Xu H. Licochalcone A inhibits cell proliferation, migration, and invasion through regulating the PI3K/AKT signaling pathway in oral squamous cell carcinoma. Onco Targets Ther 2019;12:4427-35. [PMID: 31239711 DOI: 10.2147/OTT.S201728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
81 Li R, Jiang S, Li W, Hong H, Zhao C, Huang X, Zhang Z, Li H, Chen H, Bo X. Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types. RNA Biol 2019;16:1010-21. [PMID: 31046554 DOI: 10.1080/15476286.2019.1607714] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
82 Kurihara-Shimomura M, Sasahira T, Shimomura H, Nakashima C, Kirita T. The Oncogenic Activity of miR-29b-1-5p Induces the Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma. J Clin Med 2019;8:E273. [PMID: 30813466 DOI: 10.3390/jcm8020273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
83 Yang Y, Chen D, Liu H, Yang K. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma. Cell Death Dis 2019;10:41. [PMID: 30674868 DOI: 10.1038/s41419-018-1280-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 89] [Article Influence: 16.0] [Reference Citation Analysis]
84 Qiu YL, Liu YH, Ban JD, Wang WJ, Han M, Kong P, Li BH. Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma. Oncol Rep 2019;41:895-907. [PMID: 30431131 DOI: 10.3892/or.2018.6870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
85 Kurihara-Shimomura M, Sasahira T, Nakashima C, Kuniyasu H, Shimomura H, Kirita T. The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells. Int J Mol Sci 2018;19:E2907. [PMID: 30257458 DOI: 10.3390/ijms19102907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]